{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T21:57:57Z","timestamp":1780523877309,"version":"3.54.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jsps.2024.102039","type":"journal-article","created":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T16:29:13Z","timestamp":1710606553000},"page":"102039","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Safety of prolonged use of metoclopramide and domperidone as treatment for chronic gastrointestinal dysmotility disorders in patients with systemic sclerosis"],"prefix":"10.1007","volume":"32","author":[{"given":"Saad","family":"Alkhowaiter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha M.","family":"Al Rasheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuha","family":"Alammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansour","family":"Altuwaijri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suliman","family":"Alshankiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed A.","family":"Omair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Alsahafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.jsps.2024.102039_b0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.gtc.2014.11.008","article-title":"Prokinetics in gastroparesis","volume":"44","author":"Acosta","year":"2015","journal-title":"Gastroenterol. Clin. North Am."},{"key":"10.1016\/j.jsps.2024.102039_b0010","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1007\/s10620-016-4333-9","article-title":"Adverse effects of domperidone: prolonged QuesT for knowledge?","volume":"61","author":"Bashashati","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jsps.2024.102039_b0015","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2165\/00003495-198224050-00002","article-title":"Domperidone. a review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic","volume":"24","author":"Brogden","year":"1982","journal-title":"Drugs"},{"key":"10.1016\/j.jsps.2024.102039_b0020","first-page":"357","article-title":"Use of metoclopramide, domperidone, and cisapride in the management of diabetic gastroparesis","volume":"9","author":"Brown","year":"1990","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.jsps.2024.102039_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2022.102211","article-title":"Current advances in the treatment of systemic sclerosis","volume":"64","author":"Bukiri","year":"2022","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.jsps.2024.102039_b0030","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMcp062614","article-title":"Clinical practice","volume":"356","author":"Camilleri","year":"2007","journal-title":"Diabetic Gastroparesis. N. Engl. J. Med."},{"key":"10.1016\/j.jsps.2024.102039_b0035","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0753-3322(91)90048-X","article-title":"Neuroleptic malignant syndrome induced by metoclopramide","volume":"45","author":"Donnet","year":"1991","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jsps.2024.102039_b0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.rdc.2017.09.002","article-title":"Gastrointestinal and hepatic disease in systemic sclerosis","volume":"44","author":"Frech","year":"2018","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"10.1016\/j.jsps.2024.102039_b0045","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1891\/2158-0782.9.1.10","volume":"9","author":"Hale","year":"2018","journal-title":"Domperidone versus metoclopramide. Clin. Lact."},{"key":"10.1016\/j.jsps.2024.102039_b0050","article-title":"Metoclopramide","author":"Isola","year":"2023","journal-title":"StatPearls."},{"key":"10.1016\/j.jsps.2024.102039_b0055","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/pds.2016","article-title":"Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case-control study","volume":"19","author":"Johannes","year":"2010","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.jsps.2024.102039_b0060","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/0091270007312258","article-title":"Metoclopramide, an increasingly recognized cause of tardive dyskinesia","volume":"48","author":"Kenney","year":"2008","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jsps.2024.102039_b0065","first-page":"273","article-title":"Gastrointestinal dysmotility in critically ill patients","volume":"31","author":"Ladopoulos","year":"2018","journal-title":"Ann. Gastroenterol."},{"key":"10.1016\/j.jsps.2024.102039_b0070","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/archinte.1989.00390110070015","article-title":"Metoclopramide-induced movement disorders: clinical findings with a review of the literature","volume":"149","author":"Miller","year":"1989","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jsps.2024.102039_b0075","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.4065\/80.8.1050","article-title":"Medication-induced hyperprolactinemia","volume":"80","author":"Molitch","year":"2005","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jsps.2024.102039_b0080","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jopan.2008.07.006","article-title":"Metoclopramide and extrapyramidal symptoms: a case report","volume":"23","author":"Moos","year":"2008","journal-title":"J. Perianesth. Nurs."},{"key":"10.1016\/j.jsps.2024.102039_b0085","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/ncpgasthep0442","article-title":"Drug insight: from disturbed motility to disordered movement\u2014a review of the clinical benefits and medicolegal risks of metoclopramide","volume":"3","author":"Pasricha","year":"2006","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jsps.2024.102039_b0090","first-page":"1230","article-title":"A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis","volume":"94","author":"Patterson","year":"1999","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jsps.2024.102039_b0095","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41584-023-00909-5","article-title":"State-of-the-art evidence in the treatment of systemic sclerosis","volume":"19","author":"Pope","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jsps.2024.102039_b0100","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1111\/j.1572-0241.2007.01255.x","article-title":"Domperidone: review of pharmacology and clinical applications in gastroenterology","volume":"102","author":"Reddymasu","year":"2007","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jsps.2024.102039_b0105","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1007\/s10620-016-4272-5","article-title":"Domperidone to treat symptoms of gastroparesis: benefits and side effects from a large single-center cohort","volume":"61","author":"Schey","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jsps.2024.102039_b0110","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/17474124.2019.1645594","article-title":"Metoclopramide for the treatment of diabetic gastroparesis","volume":"13","author":"Shakhatreh","year":"2019","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"issue":"Suppl 1","key":"10.1016\/j.jsps.2024.102039_b0115","doi-asserted-by":"crossref","first-page":"e000782","DOI":"10.1136\/rmdopen-2018-000782","article-title":"Systemic sclerosis: state of the art on clinical practice guidelines","volume":"4","author":"Smith","year":"2018","journal-title":"RMD Open"},{"key":"10.1016\/j.jsps.2024.102039_b0120","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2036.2004.01867.x","article-title":"Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics","volume":"19","author":"Tonini","year":"2004","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jsps.2024.102039_b0125","doi-asserted-by":"crossref","first-page":"e13339","DOI":"10.1111\/nmo.13339","article-title":"Gastrointestinal dysmotility: a qualitative exploration of the journey from symptom onset to diagnosis","volume":"30","author":"Twist","year":"2018","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.jsps.2024.102039_b0130","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.2165\/11536840-000000000-00000","article-title":"Domperidone and ventricular arrhythmia or sudden cardiac death: a population-based case-control study in the Netherlands","volume":"33","author":"van Noord","year":"2010","journal-title":"Drug Saf."},{"key":"10.1016\/j.jsps.2024.102039_b0135","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","article-title":"Systemic sclerosis","volume":"401","author":"Volkmann","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jsps.2024.102039_b0140","author":"Who"},{"key":"10.1016\/j.jsps.2024.102039_b0145","unstructured":"WHO model list of essential medicines: 22nd list (2021). World Health Organization. https:\/\/www.who.int\/publications\/i\/item\/WHO-MHP-HPS-EML-2021.02 (accessed May 2023)."}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016424000896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016424000896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:25:09Z","timestamp":1736184309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319016424000896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1319016424000896"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2024.102039","relation":{},"ISSN":["1319-0164"],"issn-type":[{"value":"1319-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of prolonged use of metoclopramide and domperidone as treatment for chronic gastrointestinal dysmotility disorders in patients with systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2024.102039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}],"article-number":"102039"}}